6 completed. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 6 |
Follow Hearing Loss: new trials by email Literature Review of Hearing Loss trials Research Report on Hearing Loss
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Omega-3-Based Nutraceutical Supplementation as Adjunctive Therapy in Adults With Otitis Media With Effusion: A Multicenter, Double-Blind, Randomized Placebo-Controlled Trial Omega-3-based nutraceutical combination (Otoair Flogo), Bilastine 20 mg, Placebo Tablet or Capsule - Otits Media With Effusion | Phase 4 | Completed | Isola Tiberina - Gemelli Isola Hospital, Rome, Italy | 501 | 2025-10-01 | 2026-07-23 |
| Treating Hearing Loss to Improve Mood and Cognition in Older Adults Phonak Audeo B-R 90 hearing aid device (Active), Duloxetine or escitalopram, Audeo B-R 90 hearing aid device (Sham) - Hearing Loss, Depression | Phase 4 | Completed | New York State Psychiatric Institute | 25 | 2018-05-30 | 2021-10-04 |
| Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment Dexamethasone Phosphate - Cisplatin Ototoxicity | Phase 4 | Completed | Meir Medical Center | 30 | 2011-06-01 | 2014-07-17 |
| Effect of Stellate Ganglion Block on Meniere's Disease stellate ganglion block, 0.25mg, fludiazine, 25mg cephadol@ (diphenidol) - Vertigo, Meniere Disease | Phase 4 | Completed | Chi Mei Medical Hospital | 20 | 2010-04-01 | 2012-04-11 |
| Chlorobutanol, Potassium Carbonate, and Irrigation in Cerumen Removal drops intilation (Taponoto ® ), drops intilation (Otocerum®), drops intilation (Placebo) - Ear Infection, Hearing Loss | Phase 4 | Completed | Hospital Clinic of Barcelona | 90 | 2008-09-01 | 2008-10-03 |
| Bilateral Benefit in Adult Users of the HiRes 90K Bionic Ear System HiRes 90K Bionic Ear System - Hearing Loss | Phase 4 | Completed | Advanced Bionics | 32 | 2004-10-01 | 2012-03-01 |
Vertigo (2) · Depression (1) · Hearing Loss, Conductive (1) · Meniere Disease (1) · Otitis (1) · Otitis Media with Effusion (1) · Ototoxicity (1)
Ear Diseases (6) · Hearing Disorders (6) · Nervous System Diseases (6) · Neurologic Manifestations (6) · Otorhinolaryngologic Diseases (6) · Pathological Conditions, Signs and Symptoms (6) · Sensation Disorders (6) · Signs and Symptoms (6) · Labyrinth Diseases (2) · Vestibular Diseases (2) · Behavior (1) · Behavioral Symptoms (1) · Chemically-Induced Disorders (1) · Drug-Related Side Effects and Adverse Reactions (1) · Endolymphatic Hydrops (1)
Adrenal Cortex Hormones (1) · Calcium Dobesilate (1) · Capsules (1) · Duloxetine Hydrochloride (1) · Escitalopram (1) · Fatty Acids, Omega-3 (1) · Magnesium (1) · Mometasone Furoate (1) · Otocerum (1) · Vitamin B 6 (1) · bilastine (1) · deflazacort (1) · dexamethasone 21-phosphate (1) · diphenidol (1)
Advanced Bionics (1) · Chi Mei Medical Hospital (1) · Hospital Clinic of Barcelona (1) · Isola Tiberina - Gemelli Isola Hospital, Rome, Italy (1) · Meir Medical Center (1) · New York State Psychiatric Institute (1)
United States (2) · Israel (1) · Italy (1) · Spain (1) · Taiwan (1)
Bret Rutherford, MD (1) · Mary Joe Osberger (1) · Tal M Marshak, MD (1) · Yung-Song Lin, M.D. (1)
R21AG059130 (1)